PubMed · 1905748
Sensitive competitive-binding ELISAs for quantifying free kappa and lambda light chains in cerebrospinal fluid.
Abstract
Simple, sensitive, and fully standardized solid-phase enzyme-linked competitive binding immunoassays to quantify free kappa and lambda immunoglobulin light chains are described. The assays were developed to measure the concentration of free light chains in cerebrospinal fluid (CSF), in part because elevated levels of free kappa light chains have utility as a diagnostic marker for multiple sclerosis (MS). Polyclonal rabbit antibodies raised against pooled Bence Jones proteins are bound to solid-phase Staphylococcal protein A and used as the primary antisera in this assay. A pool of Bence Jones proteins isolated from the urine of 10 individuals with multiple myeloma are used as a biotin-labeled ligand and to develop a standard curve. The assays as described are sensitive to the low nanogram range and are specific for free kappa or lambda light chains. The assays were found to have acceptable precision, and results correlated highly with concentrations determined using competitive-binding radioimmunoassays previously described.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
G L Stanescu, A R Swick, V K Tuohy, R A Rudick. 1991. Sensitive competitive-binding ELISAs for quantifying free kappa and lambda light chains in cerebrospinal fluid.. https://doi.org/10.1002/jcla.1860050310
Cite the original work for its findings. Save a collection to share your selection of sources.